|
|
|
Insider
Information: |
Vitullo Nicole |
Relationship: |
10% Owner |
City: |
Richmond |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
26 |
|
Direct
Shares |
3,769,432 |
|
Indirect Shares
|
2,643,947 |
|
|
Direct
Value |
$41,248,064 |
|
|
Indirect Value
|
$8,824,717 |
|
|
Total
Shares |
6,413,379 |
|
|
Total
Value |
$50,072,781 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-29.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-12 |
8,000 |
Premium* |
|
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2005-07-28 |
668 |
2005-07-28 |
0 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-04 |
3,333 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2006-05-09 |
100,355 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-28 |
5,142 |
2008-04-24 |
56,718 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
3,019 |
2011-12-22 |
50,643 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
Director |
2020-01-28 |
0 |
2020-01-28 |
0 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
Director, 10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2023-06-15 |
36,918 |
2019-03-21 |
0 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2017-12-11 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
2016-11-01 |
0 |
2013-08-27 |
32,091 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
2014-05-07 |
1,973,389 |
2014-05-01 |
0 |
Premium* |
|
Marinus Pharmaceuticals Inc |
MRNS |
Director |
2022-02-04 |
6,442 |
2021-03-16 |
0 |
Premium* |
|
Colucid Pharmaceuticals, Inc. |
CLCD |
10% Owner |
2016-09-09 |
0 |
|
0 |
Premium* |
|
Syndax Pharmaceuticals Inc |
SNDX |
10% Owner |
2016-03-08 |
1,743,854 |
2016-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
164 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MRNS |
Marinus Pharmaceuticals I... |
Director |
|
2022-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
6,442 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
36,918 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2011-12-22 |
4 |
B |
$1.45 |
$680,263 |
I/I |
469,147 |
50,643 |
1.5 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2011-09-16 |
4 |
B |
$2.00 |
$7,000,000 |
I/I |
3,500,000 |
169,251 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2010-10-06 |
4 |
OE |
$3.02 |
$75,500 |
D/D |
25,000 |
25,000 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2017-08-10 |
4 |
OE |
$3.11 |
$8,750,000 |
I/I |
2,811,245 |
37,885 |
0 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2010-11-29 |
4 |
B |
$4.00 |
$9,399,996 |
I/I |
2,349,999 |
110,555 |
1.5 |
- |
|
TBRA |
Tobira Therapeutics Inc |
10% Owner |
|
2013-08-27 |
4 |
B |
$4.00 |
$3,000,000 |
I/I |
750,000 |
2,571,117 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2008-12-08 |
4 |
B |
$4.47 |
$1,110,397 |
I/I |
248,411 |
4,173 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2008-12-09 |
4 |
B |
$4.93 |
$1,192,518 |
I/I |
241,890 |
8,237 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2017-08-10 |
4 |
D |
$5.06 |
$8,742,061 |
I/I |
(1,727,680) |
25,159 |
0 |
- |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2014-05-01 |
4 |
OE |
$5.16 |
$625,144 |
D/D |
121,152 |
1,991,202 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2008-02-20 |
4 |
A |
$5.34 |
$14,999,996 |
I/I |
2,808,988 |
90,369 |
0 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2013-07-15 |
4 |
B |
$6.03 |
$7,999,992 |
I/I |
1,327,491 |
1,897,336 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2013-07-15 |
4/A |
B |
$6.03 |
$7,999,992 |
I/I |
1,327,491 |
1,857,036 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2020-01-28 |
4 |
D |
$6.30 |
$229,515 |
D/D |
(36,431) |
0 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2020-01-28 |
4 |
D |
$6.30 |
$21,536,808 |
I/I |
(3,418,541) |
0 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-24 |
4 |
B |
$6.75 |
$337,500 |
I/I |
50,000 |
40,445 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-12 |
4 |
B |
$6.90 |
$427,800 |
I/I |
62,000 |
32,898 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-10 |
4 |
B |
$6.93 |
$584,892 |
I/I |
84,400 |
30,959 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-11 |
4 |
B |
$6.93 |
$371,448 |
I/I |
53,600 |
31,858 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-20 |
4 |
B |
$6.93 |
$1,732,500 |
I/I |
250,000 |
37,090 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-23 |
4 |
B |
$6.93 |
$1,039,500 |
I/I |
150,000 |
39,606 |
1.5 |
- |
|
CLCD |
Colucid Pharmaceuticals, ... |
10% Owner |
|
2016-04-28 |
4 |
S |
$6.96 |
$1,636 |
D/D |
(235) |
3,284 |
0 |
- |
|
CLCD |
Colucid Pharmaceuticals, ... |
10% Owner |
|
2016-04-28 |
4 |
S |
$6.96 |
$1,042,364 |
D/D |
(149,765) |
2,096,137 |
0 |
- |
|
164 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|